Recherche
Résultats 1-9 de 9
-
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood, American Society of Hematology, 20-02-2021, 137 (25), 3495–3506Article dans une revue scientifique -
Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients
Blood, 11-07-2015, 119, 5126-5132Article dans une revue scientifique -
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Blood, 11-07-2015, 117, 1834-1839Article dans une revue scientifique -
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)
Blood, 11-07-2015, 122, 1137-1143Article dans une revue scientifique -
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
Blood, 11-07-2015, 118, 37-43Article dans une revue scientifique -
Obinutuzumab plus lenalidomide (GALEN) in advanced, previously untreated follicular lymphoma in need of systemic therapy.
Blood, American Society of Hematology, 25-12-2021, 139 (15), 2338–2346Article dans une revue scientifique -
Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA.
Blood, American Society of Hematology, 20-11-2020, 137 (17), 2307–2320Article dans une revue scientifique -
High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP.
Blood, 27-01-2020, 135 (16), 1396-1405Article dans une revue scientifique -
Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy: A DESCAR-T analysis.
Blood, 21-09-2022, 140 (24), 2584-2593Article dans une revue scientifique